Patent · US Expired

Non-nucleoside reverse transcriptase inhibitors

US7405310B2 · kind B2 · utility

0Cited by

1References

5Claims

0Family size

Assignee

MEDIVIR AB · SE

Inventors

Stefan Lindstrom · Huddinge, SE
Christer Sahlberg · Stuvsta-Snättringe, SE
Hans Wallberg · Stuvsta-Snättringe, SE
Genaidy Kalyanov · Stuvsta-Snättringe, SE
Lourdes Salvador ODEN · Huddinge, SE
Lotta Naeslund · Uppsala, SE

Key dates

Filing date	Mar 2, 2005
Grant date	Jul 29, 2008
Priority date	—
Expiry date	Apr 21, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to non-nucleoside reverse transcriptase inhibitors active against HIV-1 and having an improved resistance and pharmacokinetic profile. The invention further relates to novel intermediates in the synthesis of such compounds and the use of the compounds in antiviral methods and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.